28 September 2016
PUBLICATION OF SUPPLEMENTARY PROSPECTUS
The following Supplementary Prospectus has been approved by the UK Listing Authority and is available for viewing:
Supplementary Prospectus dated 28 September 2016 relating to the base prospectus dated 18 December 2015 (the "Prospectus") for the GBP 1,000,000,000 Euro Medium Term Note Programme of Close Brothers Finance plc, guaranteed by Close Brothers Limited.
To view the full Supplementary Prospectus or any of the documents referred to therein, please paste the appropriate URL from the following list into the address bar of your browser:
2016 Annual Report and Accounts of Close Brothers Finance plc
2016 Annual Report and Accounts of Close Brothers Limited
The Supplementary Prospectus and the documents referred to therein are also available for viewing at the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM.
For further information, please contact:
Deputy Company Secretary
Close Brothers Finance plc
10 Crown Place
London EC2A 4FT
T: +44 (0) 20 7655 3100
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus and the Supplementary Prospectus, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
DISCLAIMER - SECURITIES ACT REGISTRATION
The Notes and the Guarantee (as defined in the Prospectus) have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and the Notes may not be offered or sold within the United States or to or for the account or benefit of U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.
This information is provided by RNS